Document is current
Any future updates will be listed below
-
Authors
Beddows, Ian https://orcid.org/0000-0001-7403-0016
Djirackor, Svetlana
Omran, Dalia K. https://orcid.org/0000-0003-4323-2621
Jung, Euihye https://orcid.org/0000-0003-1202-247X
Shih, Natalie NC
Roy, Ritu https://orcid.org/0000-0003-2065-7846
Hechmer, Aaron
Olshen, Adam
Adelmant, Guillaume https://orcid.org/0000-0003-4075-5486
Tom, Ann
Morrison, Jacob
Adams, Marie https://orcid.org/0000-0001-7909-2339
Rohrer, Daniel C. https://orcid.org/0000-0002-1784-9196
Schwartz, Lauren E.
Pearce, Celeste Leigh
Auman, Heidi
Marto, Jarrod A. https://orcid.org/0000-0003-2086-1134
Drescher, Charles W.
Drapkin, Ronny https://orcid.org/0000-0002-6912-6977
Shen, Hui https://orcid.org/0000-0001-9767-4084
- License Information
-
More Information
Article History
Received: 14 July 2024
Accepted: 12 March 2025
First Online: 26 March 2025
Competing interests
: J.A.M. is a founder, equity holder, and advisor to Entact Bio, serves on the SAB of 908 Devices, and receives or has received sponsored research funding from Vertex, AstraZeneca, Taiho, Springworks, TUO Therapeutics, and Takeda. R.D. serves as an advisor to Repare Therapeutics. The remaining authors declare no competing interests.
